Georg Hempel

22PUBLICATIONS
44CO-AUTHORS
Molecular targetsPharmacogenomicsMedical infection agents (incl. prions)Biologically active moleculesClinical pharmacy and pharmacy practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 27, 2026
HPLC-MS Quantification of Multiple Tyrosine Kinase Inhibitors in Patients with Solid Tumors: Method Validation and Clinical Application.

|Mar 03, 2026
Role of Pharmacogenetics on Tramadol Pharmacokinetics: A Population Pharmacokinetic Model.

Paula Soria-Chacartegui, Gudrun Würthwein, Pablo Zubiaur

|Feb 26, 2025
Physiologically Based Pharmacokinetic Model of CYP2D6 Associated Interaction Between Venlafaxine and Strong Inhibitor Bupropion-The Influence of Age-Relevant Changes and Inhibitory Dose to Classify Therapeutical Success and Harm.

Ulrich Ruben Luecht, Wolfgang Scholz, Ann-Kathrin Geiben

|Jun 25, 2024
Development and Validation of a High-Performance Liquid Chromatography With Ultraviolet Detection Method to Facilitate Therapeutic Monitoring of Teicoplanin Using Dried Blood Spots.

Ola Ramadan, Patrick Opitz, Georg Hempel

|Mar 17, 2024
Proof of concept of physiologically based pharmacokinetic modelling in paediatric acute lymphoblastic leukaemia.

Thomas Bauch, Georg Hempel

|Jul 13, 2022
Population pharmacokinetic modelling of imatinib in healthy subjects receiving a single dose of 400 mg.

Yi-Han Chien, Gudrun Würthwein, Pablo Zubiaur

Pageof 4

Frequent Collaborators

4 joint publications

Gudrun Würthwein

3 joint publications

Pablo Zubiaur

3 joint publications

Francisco Abad-Santos

2 joint publications

Joachim Boos